Local Recurrence After Nephron Surgery: What to Do? An Italian Multicentric Registry
Authors:
- Angelo PorrecaAPAngelo Porreca
- Filippo MarinoFilippo Marino
- Davide De MarchiDMDavide De Marchi
- Marco GiampaoliMGMarco Giampaoli
- Daniele D’agostinoDDDaniele D’agostino
- Francesca SimonettiFSFrancesca Simonetti
- Antonio AmodeoAAAntonio Amodeo
- Paolo CorsiPCPaolo Corsi
- Francesco ClapsFCFrancesco Claps
- Alessandro CrestaniACAlessandro Crestani
- Riccardo BertoloRiccardo Bertolo
- Alessandro AntonelliAAAlessandro Antonelli
Open Access
Abstract
Introduction and Objectives: Local recurrence (LR) in patients treated with surgery for renal cell carcinoma (RCC) remains a significant clinical challenge that requires thorough investigation. Our study aimed to identify the relative risk factors and explore the optimal clinical management of LR. Materials and Methods: We conducted a non-randomized, observational, retrospective multicentric registry involving multiple Italian urological centers. We included patients treated with surgery (either nephron-sparing or radical nephrectomy) who later developed LR, defined as recurrence in the ipsilateral kidney or renal fossa. Patients with hereditary syndromes or metastatic disease at the time of LR diagnosis were excluded. Results: We reported 135 cases of LR with the following characteristics: most primary lesions were monofocal (85.7%), with a median size of 42 mm (23–53), the median R.E.N.A.L. score was 7 (6–8), and the median Padua score was 7 (6–9). Patients were treated with robot-assisted techniques in 59% of cases, laparoscopic surgery in 32.4%, and open surgery in 8.6%. Nephron-sparing surgery was performed in 75.2% of cases. Ischemia occurred in 61% of the cases, with a median ischemia time of 21 min (15.5–24). Intraoperative complications occurred in 3.8% of cases, while postoperative complications were reported in 13.8%, all of which were grade ≤3 according to the Clavien–Dindo classification. The primary tumors were pT1a in 43.5% of cases, pT1b in 26.3%, pT2 in 14.7% and pT3 in 15.5%. Histologically, 84% of cases were clear cell, 11.3% papillary type 1 or 2, and 3.7% chromophobe. Sarcomatoid/rhabdoid variants were present in 10.5% of cases. The median rate of LR was 1.3% (range 0.2–3.6), while the median time to LR was 18 months (12–39). LR occurred in the ipsilateral kidney in 70.5% of cases and in the ipsilateral renal fossa in 29.5%. The median rate of PSM in LR cases at initial surgery was 2.4% (range 0–4.3), while the median rate of negative surgical margin (NSM) in LR cases at initial surgery was 0.1 (0–0.3). Following LR diagnosis, most patients (49.2%) underwent surgery, 29.1% received cryoablation or radiotherapy, 17.1% received systemic treatment alone, and 4.6% followed a watchful waiting/active surveillance approach. At a median follow-up of 62 months, the highest oncological control in terms of 5-year cancer-specific survival and overall survival rates was achieved in surgically treated patients. The PSM, the histological variant, and their combination were found to be independent variables correlated with the occurrence of LR, with relative risks of 3.62, 2.71, and 8.12, respectively. Conclusions: LR after nephron-sparing or radical nephrectomy represents a significant clinical dilemma. Known risk factors are not always sufficient to predict recurrence, emphasizing the necessity of consistent radiological follow-up per guideline recommendations. Early detection of recurrence and a multidisciplinary approach involving expert centers are crucial for optimizing patient outcomes.Keywords
Funding Information
- “Ricerca Corrente” funding from the Italian Ministry of Health
This publication has 37 references indexed in Scilit:
- Cryoablation of renal tumors: long-term follow-up from a multicenter experienceAbdominal Radiology, 2021
- Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer CenterEuropean Urology Focus, 2019
- Comparison of long‐term outcomes of laparoscopic and robot‐assisted laparoscopic partial nephrectomyThe Kaohsiung Journal of Medical Sciences, 2019
- Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single InstitutionEuropean Urology Oncology, 2019
- Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 YearsClinical Genitourinary Cancer, 2019
- Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre studyWorld Journal of Urology, 2018
- Surgical Margins in Nephron-Sparing Surgery for Renal Cell CarcinomaCurrent Urology Reports, 2017
- Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter studyJournal of Surgical Oncology, 2016
- Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinomaInternational Urology and Nephrology, 2016
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987